An interventional study of H-reflex and Bone myoregulation reflex in Osteoporosis Postmenopausal, sponsored by Istanbul Physical Medicine Rehabilitation Training and Research Hospital. Recruiting at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-11-28.
Sponsored by Istanbul Physical Medicine Rehabilitation Training and Research Hospital · Not applicable, Interventional, and Basic science
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 20 studies in Osteoporosis, Postmenopausal with a site in Turkey — 4 open to participants now, 5 under way, none of them phase 3. Osteoporosis, Postmenopausal · Turkey.
Among the 20 studies in Osteoporosis, Postmenopausal with a site in Turkey, this one is the 11th largest by planned enrollment of the 11 interventional ones that give a count, is one of 3 that started in 2025, is one of 6 with no phase, and was the 17th registered.
334 studies on the registry are indexed under Osteoporosis, Postmenopausal; 28 are open to participants now.
Browse Osteoporosis, Postmenopausal studies →4 of the 20 studies in Osteoporosis, Postmenopausal with a site in Turkey are open now. Recruiting first, the newest first:
Kanuni Sultan Suleyman Training and Research Hospital · Sites in Turkey
Ages 45+ · Women only
Kirsehir Ahi Evran Universitesi · Sites in Turkey
Ages 40–65 · Healthy volunteers
Beylikduzu State Hospital · Sites in Turkey
Ages 50–75 · Women only · Healthy volunteers
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 20 Osteoporosis, Postmenopausal studies recruiting now, 8 (40%) set no upper age limit and 8 (40%) stop at 75 or younger; 1 takes children under 18; 7 take healthy volunteers.
This study: 18 Years to 65 Years · female · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
20 studies; the count open now beside each. This study's row is marked.
First in 2004; this study’s year is marked. 3 started in 2025.
This study's planned enrollment of 24 is below the median of 119 across 264 interventional studies indexed under Osteoporosis, Postmenopausal.
Median enrollment 53 across the 11 interventional studies, 98 across the 9 observational. Of the 11 that completed or were terminated, 2 (18%) have results posted.
This tab as a report to print or save as PDF → With an account.
5 of 20 have an industry lead sponsor. The 10 most frequent:
Istanbul Physical Medicine Rehabilitation Training and Research Hospital is the lead sponsor of 123 studies on the registry; 26 are open to participants now.
Istanbul Physical Medicine Rehabilitation Training and Research Hospital has 1 study filed under Osteoporosis, Postmenopausal — fewer than ten, so there is no comparison to draw.
1 of the studies in Osteoporosis, Postmenopausal with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07677072Kanuni Sultan Suleyman Training and Research HospitalCan Serum Lumican Level Identify a Hidden Fragility Phenotype Beyond Bone Mineral Density in Postmenopausal Women? | 2026-12-01 |
Add it to your calendar (.ics) → With an account.
Among the 20 studies in Osteoporosis, Postmenopausal with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Weight-bearing exercises (e.g., running, jumping, whole-body vibration) are widely practiced due to their beneficial effects on bone development and their role in the prevention and treatment of osteoporosis. However, the underlying neuroregulatory mechanisms responsible for these positive effects have not yet been fully understood. Two main neuromodulatory mechanisms have been proposed in the literature: (i) spinal reflexes originating from muscle spindles (stretch reflex, tonic vibration reflex), and (ii) the bone myoregulation reflex (BMR) based on load-sensitive osteocytes.
It is well established that increased voluntary contraction and the associated rise in background EMG activity, that is, motor neuron pool activity, enhance muscle spindle-based reflex responses (such as the H-reflex and tendon reflex). In contrast, it has been demonstrated that the H-reflex is suppressed during bone-loading activities such as single-leg stance, jumping, or whole-body vibration.
This study is based on two hypotheses:
If this inhibition originates from load-sensitive receptors-osteocytes-and thus from the BMR, then in osteoporosis, where osteocyte number and function are reduced, H-reflex suppression will be diminished.
The aim of this research is to test these hypotheses. Confirmation of these assumptions would suggest that reflex control during weight-bearing exercise occurs predominantly through osteocyte-mediated BMR mechanisms rather than muscle spindle-based mechanisms such as the stretch or tonic vibration reflex.
EMG and Force Data Acquisition
Surface EMG signals from the soleus muscle, accelerometer data from the whole-body vibration platform, and force sensor data will be collected at a 2 kHz sampling rate using a data acquisition system (CED 3601 Power 1401 MKII digital-to-analogue converter and CED 1902 Quad System MKIII amplifier). Data analysis will be performed using Spike2 version 7.20 software.
Subjects will be tested while standing on both feet. A force load cell (FC2231-0000-0100-L Compression Load Sensor, France) will be placed under the right heel of the subjects to obtain real-time readings of the weight applied to the right heel.
Before attaching the electrodes, any hair on the skin will be shaved, and the skin will be cleaned with alcohol wipes to remove surface oils. An ECG gel will be applied to increase skin conductivity.
A PowerPlate Pro5 (London, UK) device will be used to apply whole-body vibration.
________________________________________ H-reflex Measurement
A cathode electrode (1 cm diameter round electrode) will be positioned over the tibial nerve in the right popliteal fossa, and an anode electrode (10 × 10 cm) will be placed over the suprapatellar area. Stimulation will be delivered using a constant-current stimulator [model DS7A, Digitimer Ltd, Hertfordshire, UK] with monophasic rectangular current pulses of 1 ms duration. The current intensity will start at 5 mA and will be incrementally increased. The intensity required to obtain the recruitment curve of the H-reflex and the maximum M-response (Mmax) will be determined. A current intensity that elicits an M-response of 10-30% of Mmax will be used to minimize variations in H-reflex amplitude depending on stimulus intensity.
H-reflex will be measured in six different conditions. First, subjects will be asked to place 10%, 30%, 50%, 70%, and 100% of their body weight on their right leg in a random order. A monitor displaying real-time feedback of the weight applied to the right leg will be placed in front of the subjects to help stabilize the target load. The target weight percentage will be indicated on the monitor. For each load condition, 10 H-reflex measurements will be obtained at 10-second intervals.
Afterward, a 1-minute-long 30 Hz low-amplitude (1.2 mm) whole-body vibration will be applied to the subjects, and the H-reflex will be measured every 5 seconds.
To assess motor neuron activity, the EMG activity in the 100 ms preceding the electrical stimulation will be quantified as RMS amplitude.
________________________________________ Bone Myoregulation Reflex
10-second long low-amplitude (1.2 mm) whole-body vibrations of 30 Hz, 32 Hz, 34 Hz, and 36 Hz will be applied to the subjects. Cumulative averaging method will be used to measure latency of bone myoregulation reflex.
________________________________________ Sample Size Calculation
In this study, the H-reflex amplitude will be measured under five different loading conditions and during whole-body vibration in two groups. Assuming an effect size (partial eta squared) of 0.06, an alpha error level of 0.05, and a statistical power of 0.9, the minimum required sample size will be calculated as 12 subjects per group, for a total of 24 subjects. The sample size calculation will be performed using G*Power version 3.1.9.4 (Franz Faul, Universität Kiel, Germany).
________________________________________ Statistical Analysis
The normality of data distribution will be assessed using the Shapiro-Wilk test. Variables showing a normal distribution will be presented as mean ± standard deviation, whereas non-normally distributed variables will be summarized as median (interquartile range).
H-reflex amplitude and background EMG activity measured under five different loading conditions and during whole-body vibration will be compared using repeated-measures analysis of variance (ANOVA) when the assumption of normality is met. Tukey or Bonferroni post-hoc tests will be applied when appropriate. When the normality assumption is violated, the Friedman test will be used, and pairwise comparisons will be performed using the Wilcoxon test. Bonferroni correction will be applied for post-hoc analyses.
All statistical analyses will be conducted using SPSS software (version 18.0; SPSS Inc., Chicago, IL, USA).
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Periods have stopped for good: usually no period for 12 months in a row without another medical reason, sometimes confirmed by a blood test (FSH).
Postmenopausal
Periods have stopped for good: usually no period for 12 months in a row without another medical reason, sometimes confirmed by a blood test (FSH).
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Subjects with diagnosed femoral osteoporosis will be in this arm. Femoral osteoporosis is defined as T-scores of -2.5 or lower in femoral neck or total femur obtained in dual energy x-ray absorptiometry. Subjects will have their H-reflex amplitude measured in 6 different settings and will be applied 10 seconds whole-body vibration in 4 different frequencies to measure bone mroregulation reflex.
Diagnostic Test: H-reflex · Diagnostic Test: Bone myoregulation reflex
Subjects who do not have osteoporosis or osteopenia will be in this arm. Subjects in this group will have L1-L4, L2-L4, femoral neck and total femur T-scores of greater than -1 obtained in dual energy x-ray absorptiometry. Subjects will have their H-reflex amplitude measured in 6 different settings and will be applied 10 seconds whole-body vibration in 4 different frequencies to measure bone mroregulation reflex.
Diagnostic Test: H-reflex · Diagnostic Test: Bone myoregulation reflex
H-reflex will be measured during 5 different mechanical loads and whole body vibration.
Also known as: Hoffmann's reflex
Bone myoregulation reflex will be measured by applying 10 seconds whole body vibration of 4 different frequencies.
H-reflex Amplitude
H reflex will be measured 10 times each in 5 different mechanical loads and during 1 minute whole-body vibration. Average amplitude of 10 measurements will be calculated.
Time frame: During the day of testing
Bone myoregulation reflex latency
10 seconds whole-body vibration in 4 different frequencies will be applied to subjects. Cumulative averaging method will be used to calculate bone myoregulation reflex latency.
Time frame: During the day of testing
Plan to share: Yes — All collected data will be shared
Supporting information: Study protocol, Statistical analysis plan
Time frame: For 5 years after the publication date
Access criteria: The individual participant data (IPD) that support the findings of this study will be available from the corresponding author upon reasonable request and with permission of the Istanbul Physical Medicine and Rehabilitation Training and Research Hospital Ethics Committee. Data will be anonymized prior to sharing.
Data sharing details ↗ · istanbulftreah.saglik.gov.tr
No publications or documents are linked to this record.
Started Nov 2025 (actual). Primary completion is estimated for Mar 2026, 4 months after the start.
Of 48 non-industry interventional studies with no phase under Osteoporosis, Postmenopausal, half reached primary completion within 16 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 34. This study's planned 4 months is below that.
Counting every sponsor, half of 51 studies reached it within 17 months; a quarter within 9 and three quarters within 34.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Osteoporosis, Postmenopausal →
Istanbul Physical Medicine Rehabilitation Training and Research Hospital →